Laxatives Market Analysis and Global Forecast 2023-2033
Price range: $ 1,390.00 through $ 5,520.00
Laxatives Market Research Report: Information By Drug Type (Hyperosmotic and Bulk-Forming), By Route of Administration (Oral and Rectal), By Indication (Chronic Constipation and Irritable Bowel Syndrome), By End User (Hospitals & Clinics, Research Institutes, and Others), and Region — Forecast till 2033
The Global Laxatives Market size is projected to reach approximately USD 16.77 Billion by 2033, at a CAGR of 5.76% from 2023 to 2033. The laxatives refer to the global market for products that are used to relieve constipation and promote bowel movements. Laxatives are substances or medications that help stimulate bowel movements or soften the stool, making it easier to pass through the intestines and alleviate constipation, which is a condition characterized by infrequent or difficult bowel movements. The laxatives market includes a wide range of products, including over-the-counter (OTC) laxatives, prescription laxatives, and natural or herbal laxatives. These products are available in various forms, such as oral tablets, capsules, powders, liquids, suppositories, and enemas. Laxatives may contain different active ingredients that work through different mechanisms, such as increasing stool bulk, softening the stool, lubricating the intestines, or stimulating the muscles of the intestines to contract.
COVID-19 Impact Analysis
The COVID-19 pandemic had a significant impact on the laxatives market, with increased demand, supply chain disruptions, changing consumer behavior, and a shift towards self-care and e-commerce being notable trends. It is important to note that the impact may vary across regions and over time as the pandemic situation evolve.
Laxatives Market Analysis Market Dynamics
The Factor affecting the overall Laxatives market as described below:
Drivers:
Increasing prevalence of constipation due to sedentary lifestyles
Sedentary lifestyles are often associated with poor dietary habits, such as low fiber intake, inadequate hydration, and increased consumption of processed and low-nutrient foods. These dietary factors can further increase the risk of constipation by affecting stool consistency, bowel transit time, and overall gut health. As a result, the increasing prevalence of constipation due to sedentary lifestyles can drive the demand for laxatives and related products in the market. Many individuals may turn to laxatives as a short-term solution to relieve constipation and promote regular bowel movements. This, in turn, can contribute to the growth of the laxatives market as more people seek relief from constipation caused by sedentary lifestyles.
Restraint:
- Changing Consumer Preferences and Behavior
Consumer preferences and behavior are constantly evolving, and there may be shifts in consumer preferences towards other forms of digestive health management, such as dietary supplements, probiotics, or lifestyle changes. Changing consumer preferences and behavior may impact the demand for laxatives and restrain the market growth.
Opportunity:
Increasing Awareness about Digestive Health
Awareness about the importance of digestive health and the impact of constipation on overall well-being is growing among consumers. Increased education and awareness campaigns by healthcare providers, pharmaceutical companies, and other stakeholders can create opportunities for the laxatives market by driving consumer demand for products that help manage digestive health.
Laxatives Market Analysis Segment Overview
By Drug Type
Based on the Drug Type, the Laxatives market is segmented based on Hyperosmotic and Bulk-Forming. The Hyperosmotic segment is expected to hold the largest market share, This is due to several factors, such as their effectiveness in treating constipation, wide availability over-the-counter (OTC) without a prescription, and relatively fewer side effects compared to some other types of laxatives.
By Route of Administration
Based on the Route of Administration, the global Laxatives market has been divided into Oral and Rectal. The Oral segment is expected to hold the largest market share. As oral laxatives are preferred by many patients due to their non-invasive nature compared to other types of laxatives, such as rectal suppositories or enemas, which may be less comfortable or convenient for some individuals.
By Indication
Based on Indication, the global Laxatives market has been divided into Chronic Constipation and Irritable Bowel Syndrome. The Chronic Constipation segment is expected to hold the largest market share. This is because chronic constipation is a common condition that affects a significant portion of the population, especially among the older People, individuals with certain medical conditions, and those on certain medications. Chronic constipation can have a significant impact on quality of life, leading to a demand for effective and convenient treatment options.
By End User
Based on End Users, the global Laxatives market has been divided into Hospitals & Clinics, Research Institutes, and Others. The Hospitals & Clinics segment holds the largest market share of Laxatives. Hospitals and clinics often serve as the primary source of medical care for individuals with severe or chronic constipation, who may require more specialized treatment options or closer medical supervision.
Global Laxatives Market Share, by Segmentation
Laxatives Market Regional Analysis
Based on region, the global Laxatives market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to dominate the use of the Laxatives market followed by the Asia-Pacific and Europe regions.
North America Market
North America has historically been one of the dominant regions in the laxatives market. The laxatives market refers to the global market for products that are used to relieve constipation and promote bowel movements. Several factors contribute to North America’s dominance in the laxatives market. One of the key factors is the high prevalence of constipation and gastrointestinal disorders in North America, which drives the demand for laxatives. Unhealthy dietary habits, sedentary lifestyles, and other lifestyle factors can contribute to constipation, leading to a higher demand for laxative products.
Europe Market
Europe is indeed one of the major regions in the global laxatives market. The laxatives market in Europe is driven by various factors such as the increasing prevalence of constipation and other gastrointestinal disorders, changing lifestyles and dietary habits, the growing aging population, and increasing awareness about gastrointestinal health. Several types of laxatives are available in the market, including bulk-forming laxatives, stimulant laxatives, osmotic laxatives, and others. These laxatives are used for different purposes and work in different ways to relieve constipation and promote bowel movements.
Competitive Landscape
The market comprises tier-1, tier-2, and local players. With their wide product portfolios, tier-1 and tier-2 players have a global reach. Since of their strategic innovations and broad regional presence, companies such as Sanofi, Pfizer Inc, GlaxoSmithKline, and Novartis lead the global Laxatives business. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as growth, product releases, and alliances.
Prominent Players:
- Hoffmann-La Roche Ltd
- Mylan
- Teva Pharmaceutical Industries Ltd
- Sanofi
- Pfizer Inc
- GlaxoSmithKline
- Novartis
- Merck & Co Inc
- AstraZeneca
- Johnson & Johnson Private Limited
Scope of the Report
Global Laxatives Market, by Drug Type
- Hyperosmotic
- Bulk-Forming
Global Laxatives Market, by Route of Administration
- Oral
- Rectal
Global Laxatives Market, by Indication
- Chronic Constipation
- Irritable Bowel Syndrome
Global Laxatives Market, by End User
- Hospitals & Clinics
- Research Institutes
- Others
Global Laxatives Market, by Region
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Rest of Asia Pacific
- Rest of the World
| Parameters | Indicators |
|---|---|
| Market Size | 2033: $ 16.77 Billion |
| CAGR | 5.76% CAGR (2023-2033) |
| Base year | 2022 |
| Forecast Period | 2023-2033 |
| Historical Data | 2021 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Key Segmentations | Drug Type, Route of Administration, Indication, End User |
| Geographies Covered | North America, Europe, Asia-Pacific, Latin America, Middle East, Africa |
| Key Vendors | F. Hoffmann-La Roche Ltd, Mylan, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, GlaxoSmithKline, Novartis, Merck & Co Inc, AstraZeneca, Johnson & Johnson Private Limited |
| Key Market Opportunities | Increasing Awareness about Digestive Health |
| Key Market Drivers | Increasing prevalence of constipation due to sedentary lifestyles |
REPORT CONTENT BRIEF:
- High-level analysis of the current and future Laxatives market trends and opportunities
- Detailed analysis of current market drivers, restraining factors, and opportunities in the future
- Laxatives market historical market size for the year 2021, and forecast from 2023 to 2033
- Laxatives market share analysis at each product level
- Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
- Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
- To identify and understand the various factors involved in the global Laxatives market affected by the pandemic
- To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company’s past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.
Â
Press Release
Global Pharmaceutical Manufacturing Market to Reach $1.38 Trillion by 2035 with 7.35% CAGR, New Research Shows
The Global Mammography Market Is Estimated To Record a CAGR of Around 10.29% During The Forecast Period
Glue Stick Market to Reach USD 2.35 Billion by 2034
Podiatry Service Market to Reach USD 11.88 Billion by 2034
Microfluidics Technology Market to Reach USD 32.58 Billion by 2034
Ferric Chloride Market to Reach USD 10.65 Billion by 2034
Family Practice EMR Software Market to Reach USD 21.52 Billion by 2034
Electric Hairbrush Market to Reach USD 15.95 Billion by 2034
Daily Bamboo Products Market to Reach USD 143.52 Billion by 2034
Cross-border E-commerce Logistics Market to Reach USD 112.65 Billion by 2034
Frequently Asked Questions (FAQ)
What is the growth rate of the global Laxatives market?
The global Laxatives market is growing at a CAGR of ~ 76% over the next 10 years
Which region has the highest growth rate in the global Laxatives market?
Europe is expected to register the highest CAGR during 2023-2033
Which region has the largest share of the global Laxatives market?
North America holds the largest share in 2022
Who are the key players in the global Laxatives market?
Hoffmann-La Roche Ltd, Mylan, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, GlaxoSmithKline, Novartis, Merck & Co Inc, AstraZeneca, Johnson & Johnson Private Limited are the major companies operating in the global Laxatives market.
Do you offer Post Sale Support?
Yes, we offer 16 hours of analyst support to solve the queries
Do you sell particular sections of a report?
Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.
Table of Content
Chapter 1. Executive Summary Chapter 2. Scope Of Study 2.1. Market Definition 2.2. Scope Of The Study 2.2.1. Objectives of Report 2.2.2. Limitations 2.3. Market Structure Chapter 3. Evolve BI Methodology Chapter 4. Market Insights and Trends 4.1. Supply/ Value Chain Analysis 4.1.1. Raw Application Providers 4.1.2. Manufacturing Process 4.1.3. Distributors/Retailers 4.1.4. End Users 4.2. Porter’s Five Forces Analysis 4.2.1. Threat Of New Entrants 4.2.2. Bargaining Power Of Buyers 4.2.3. Bargaining Power Of Suppliers 4.2.4. Threat Of Substitutes 4.2.5. Industry Rivalry 4.3. Impact Of COVID-19 on the Laxatives Market 4.3.1. Impact on Market Size 4.3.2. End-User Trend, Preferences, and Budget Impact 4.3.3. Regulatory Framework/Government Policies 4.3.4. Key Players' Strategy to Tackle Negative Impact 4.3.5. Opportunity Window 4.4. Technology Overview 4.5. Macro factor 4.6. Micro Factor 4.7. Demand Supply Gap Analysis of the Laxatives Market 4.8. Import Analysis of the Laxatives Market 4.9. Export Analysis of the Laxatives Market Chapter 5. Market Dynamics 5.1. Introduction 5.2. DROC Analysis 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Patent Analysis 5.4. Industry Roadmap 5.5. Parent/Peer Market Analysis Chapter 6. Global Laxatives Market, By Drug Type 6.1. Introduction 6.2. Hyperosmotic 6.3. Bulk-Forming Chapter 7. Global Laxatives Market, By Route of Administration 7.1. Introduction 7.2. Oral 7.3. Rectal Chapter 8. Global Laxatives Market, By Indication 8.1. Introduction 8.2. Chronic Constipation 8.3. Irritable Bowel Syndrome Chapter 9. Global Laxatives Market, By End User 9.1. Introduction 9.2. Hospitals & Clinics 9.3. Research Institutes 9.4. Others Chapter 10. Global Laxatives Market, By Region 10.1. Introduction 10.2. North America 10.2.1. Introduction 10.2.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.2.3. Market Size and Forecast, By Country, 2023-2033 10.2.4. Market Size and Forecast, By Drug Type, 2023-2033 10.2.5. Market Size and Forecast, By Route of Administration, 2023-2033 10.2.6. Market Size and Forecast, By Indication, 2023-2033 10.2.7. Market Size and Forecast, By End User, 2023-2033 10.2.8. US 10.2.8.1. Introduction 10.2.8.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.2.8.3. Market Size and Forecast, By Drug Type, 2023-2033 10.2.8.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.2.8.5. Market Size and Forecast, By Indication, 2023-2033 10.2.8.6. Market Size and Forecast, By End User, 2023-2033 10.2.9. Canada 10.2.9.1. Introduction 10.2.9.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.2.9.3. Market Size and Forecast, By Drug Type, 2023-2033 10.2.9.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.2.9.5. Market Size and Forecast, By Indication, 2023-2033 10.2.9.6. Market Size and Forecast, By End User, 2023-2033 10.3. Europe 10.3.1. Introduction 10.3.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.3.3. Market Size and Forecast, By Country, 2023-2033 10.3.4. Market Size and Forecast, By Drug Type, 2023-2033 10.3.5. Market Size and Forecast, By Route of Administration, 2023 – 2030 10.3.6. Market Size and Forecast, By Indication, 2023-2033 10.3.7. Market Size and Forecast, By End User, 2023 – 2030 10.3.8. Germany 10.3.8.1. Introduction 10.3.8.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.3.8.3. Market Size and Forecast, By Drug Type, 2023-2033 10.3.8.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.3.8.5. Market Size and Forecast, By Indication, 2023-2033 10.3.8.6. Market Size and Forecast, By End User, 2023-2033 10.3.9. France 10.3.9.1. Introduction 10.3.9.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.3.9.3. Market Size and Forecast, By Drug Type, 2023-2033 10.3.9.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.3.9.5. Market Size and Forecast, By Indication, 2023-2033 10.3.9.6. Market Size and Forecast, By End User, 2023-2033 10.3.10. UK 10.3.10.1. Introduction 10.3.10.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.3.10.3. Market Size and Forecast, By Drug Type, 2023-2033 10.3.10.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.3.10.5. Market Size and Forecast, By Indication, 2023-2033 10.3.10.6. Market Size and Forecast, By End User, 2023-2033 10.3.11. Italy 10.3.11.1. Introduction 10.3.11.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.3.11.3. Market Size and Forecast, By Drug Type, 2023-2033 10.3.11.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.3.11.5. Market Size and Forecast, By Indication, 2023-2033 10.3.11.6. Market Size and Forecast, By End User, 2023-2033 10.3.12. Rest Of Europe 10.3.12.1. Introduction 10.3.12.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.3.12.3. Market Size and Forecast, By Drug Type, 2023-2033 10.3.12.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.3.12.5. Market Size and Forecast, By Indication, 2023-2033 10.3.12.6. Market Size and Forecast, By End User, 2023-2033 10.4. Asia-Pacific 10.4.1. Introduction 10.4.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.4.3. Market Size and Forecast, By Country, 2023-2033 10.4.4. Market Size and Forecast, By Drug Type, 2023-2033 10.4.5. Market Size and Forecast, By Route of Administration, 2023-2033 10.4.6. Market Size and Forecast, By Indication, 2023-2033 10.4.7. Market Size and Forecast, By End User, 2023-2033 10.4.8. China 10.4.8.1. Introduction 10.4.8.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.4.8.3. Market Size and Forecast, By Drug Type, 2023-2033 10.4.8.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.3.8.5. Market Size and Forecast, By Indication, 2023-2033 10.3.8.6. Market Size and Forecast, By End User, 2023-2033 10.4.8. India 10.4.8.1. Introduction 10.4.8.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.4.8.3. Market Size and Forecast, By Drug Type, 2023-2033 10.4.8.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.4.8.5. Market Size and Forecast, By Indication, 2023-2033 10.4.8.6. Market Size and Forecast, By End User, 2023-2033 10.4.9. Japan 10.4.9.1. Introduction 10.4.9.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.4.9.3. Market Size and Forecast, By Drug Type, 2023-2033 10.4.9.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.4.9.5. Market Size and Forecast, By Indication, 2023-2033 10.4.9.6. Market Size and Forecast, By End User, 2023-2033 10.4.10. South Korea 10.4.10.1. Introduction 10.4.10.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.4.10.3. Market Size and Forecast, By Drug Type, 2023-2033 10.4.10.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.4.10.5. Market Size and Forecast, By Indication, 2023-2033 10.4.10.6. Market Size and Forecast, By End User, 2023-2033 10.4.11. Rest Of Asia-Pacific 10.4.11.1. Introduction 10.4.11.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.4.11.3. Market Size and Forecast, By Drug Type, 2023-2033 10.4.11.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.4.11.5. Market Size and Forecast, By Indication, 2023-2033 10.4.11.6. Market Size and Forecast, By End User, 2023-2033 10.5. Rest Of The World (RoW) 10.5.1. Introduction 10.5.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.5.3. Market Size and Forecast, By Drug Type, 2023-2033 10.5.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.5.5. Market Size and Forecast, By Indication, 2023-2033 10.5.6. Market Size and Forecast, By End User, 2023-2033 10.5.7. Market Size and Forecast, By Region, 2023-2033 10.5.8. South America 10.5.8.1. Introduction 10.5.8.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.5.8.3. Market Size and Forecast, By Drug Type, 2023-2033 10.5.8.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.5.8.5. Market Size and Forecast, By Indication, 2023-2033 10.5.8.6. Market Size and Forecast, By End User, 2023-2033 10.5.9. Middle East and Africa 10.5.9.1. Introduction 10.5.9.2. Driving Factors, Opportunity Analyzed, and Key Trends 10.5.9.3. Market Size and Forecast, By Drug Type, 2023-2033 10.5.9.4. Market Size and Forecast, By Route of Administration, 2023-2033 10.5.9.5. Market Size and Forecast, By Indication, 2023-2033 10.5.9.6. Market Size and Forecast, By End User, 2023-2033 Chapter 11. Competitive Landscape 11.1. Introduction 11.2. Vendor Share Analysis, 2022/Key Players Positioning, 2022 Chapter 12. Company Profiles 12.1. F. Hoffmann-La Roche Ltd 12.1.1. Business Overview 12.1.2. Financial Analysis 12.1.3. Product Portfolio 12.1.4. Recent Development and Strategies Adopted 12.1.5. SWOT Analysis 12.2. Mylan 12.2.1. Business Overview 12.2.2. Financial Analysis 12.2.3. Product Portfolio 12.2.4. Recent Development and Strategies Adopted 12.2.5. SWOT Analysis 12.3. Teva Pharmaceutical Industries Ltd 12.3.1. Business Overview 12.3.2. Financial Analysis 12.3.3. Product Portfolio 12.3.4. Recent Development and Strategies Adopted 12.3.5. SWOT Analysis 12.4. Sanofi 12.4.1. Business Overview 12.4.2. Financial Analysis 12.4.3. Product Portfolio 12.4.4. Recent Development and Strategies Adopted 12.4.5. SWOT Analysis 12.5. Pfizer Inc 12.5.1. Business Overview 12.5.2. Financial Analysis 12.5.3. Product Portfolio 12.5.4. Recent Development and Strategies Adopted 12.5.5. SWOT Analysis 12.6. GlaxoSmithKline 12.6.1. Business Overview 12.6.2. Financial Analysis 12.6.3. Product Portfolio 12.6.4. Recent Development and Strategies Adopted 12.6.5. SWOT Analysis 12.7. Novartis 12.7.1. Business Overview 12.7.2. Financial Analysis 12.7.3. Product Portfolio 12.7.4. Recent Development and Strategies Adopted 12.7.5. SWOT Analysis 12.8. Merck & Co 12.8.1. Business Overview 12.8.2. Financial Analysis 12.8.3. Product Portfolio 12.8.4. Recent Development and Strategies Adopted 12.8.5. SWOT Analysis 12.9. AstraZeneca 12.9.1. Business Overview 12.9.2. Financial Analysis 12.9.3. Product Portfolio 12.9.4. Recent Development and Strategies Adopted 12.9.5. SWOT Analysis 12.10. Johnson & Johnson Private Limited 12.10.1. Business Overview 12.10.2. Financial Analysis 12.10.3. Product Portfolio 12.10.4. Recent Development and Strategies Adopted 12.10.5. SWOT Analysis Chapter 13. Key Takeaways
Connect to Analyst
Research Methodology
Our Most Viewed Report and gain instant expertise
Aesthetic Lasers And Energy Devices Market Analysis and Global Forecast 2023-2033
Electroencephalography (EEG) Equipment Market Analysis and Global Forecast 2023-2033
